Latest: Aether Industries Ltd Q1 FY27 results →All Q4 FY25 results →
A

Aether Industries Ltd

Q4 FY25Chemicals & Petrochemicals

Aether Industries Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management said on revenue, margins and capex.

Price₹1,627
Market cap₹21.1K Cr
P/E87.9
Updated23 Aug 2026
Read4 min read

The short version

Aether Industries achieved 34% volume growth in FY 2025 compared to FY 2024, with volumes rising 21% quarter-on-quarter in Q4 FY25. Aether Industries expects to maintain or grow EBITDA margins around 29%-30% in the near term, with gradual improvement beyond that.

From Aether Industries Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Aether Industries achieved 34% volume growth in FY 2025 compared to FY 2024, with volumes rising 21% quarter-on-quarter in Q4 FY25.
  • Pricing has remained stable over the past six months, supporting strong demand.
  • The company aims to shift revenue mix to 70% from CRAMS and CEM business models and 30% from large-scale manufacturing, indicating growth in higher-margin contract manufacturing segments.
  • Site-4 has been commercialized with full production and is expected to ramp up further in FY26 and FY27.
  • Site-3++ is dedicated to a key client under a CEM model, with production anticipated to start by end of Q3 FY26.

2 more points from Aether Industries Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

Read what Aether Industries Ltd said on margins in the Q4 FY25 call

Free account with your mobile number. We text a one-time code, no password.

Capital Expenditure Plans

  • Aether Industries is expanding its R&D center at Site-1, doubling the R&D capacity to support the CRAMS business model.
  • Site-3++ is being developed and dedicated to a key client under the Contract/Exclusive Manufacturing (CEM) business model, with production expected to start by end of Q3 FY 2026.
  • Site-4 has been successfully commercialized and is operating at full capacity.
  • Site-5 expansion is progressing, with two production blocks on track for commissioning by December 2025; additional 15 acres acquired at Site-5 totaling 46 acres, earmarked for large customers like Baker Hughes.
  • The company plans to invest significantly and strategically in R&D, aiming to increase R&D spend possibly to 10%-12% of revenues.

2 more points from Aether Industries Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Aether Industries Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹305 Cr, net profit ₹54 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Atul (Q4 FY25)

    Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…

  • Vidhi Specialty Food Ingredients Ltd (Q4 FY25)

    109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…

  • Chemcon Speciality Chemicals Ltd (Q4 FY25)

    54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Clean Science & Technology Ltd (Q4 FY25)

    2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Aether Industries Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Aether Industries Ltd Q4 FY25 results?

Aether Industries achieved 34% volume growth in FY 2025 compared to FY 2024, with volumes rising 21% quarter-on-quarter in Q4 FY25. Aether Industries expects to maintain or grow EBITDA margins around 29%-30% in the near term, with gradual improvement beyond that.

What is Aether Industries Ltd share price analysis?

Aether Industries Ltd currently shows a neutral. The stock trades at a P/E of 87.9 with a market cap of ₹21,093 Cr. Investors should review the full earnings analysis for detailed insights.

Is Aether Industries Ltd planning capital expenditure?

Aether Industries is expanding its R&D center at Site-1, doubling the R&D capacity to support the CRAMS business model. - Site-3++ is being developed and dedicated to a key client under the Contract/Exclusive Manufacturing (CEM) business model, with production expected to start by end of Q3 FY 2026. - Site-4 has been successfully commercialized and is operating at full capacity. - Site-5 expansion is progressing, with two production blocks on track for commissioning by December 2025; additional 15 acres acquired at Site-5 totaling 46 acres, earmarked for large customers like Baker Hughes. - The company plans to invest significantly and strategically in R&D, aiming to increase R&D spend possibly to 10%-12% of revenues. - Solar power initiatives are expanding, saving Rs.

Keep Aether Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.